Coffee consumption and cognitive function among older adults

American Journal of Epidemiology

Volumn 156, Issue 9, 2002, Pages 842-850

  Johnson Kozlow, Marilyn ^a   Kritz Silverstein, Donna ^a   Barrett Connor, Elizabeth ^a   Morton, Deborah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aged, 80 and over; Aging; Caffeine; Coffee; Cognition; Sex

Indexed keywords

CAFFEINE; ESTROGEN;

COGNITION;

ADULT; AGED; AGING; ARTICLE; BEVERAGE; COFFEE; COGNITION; DIETARY INTAKE; ESTROGEN THERAPY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGY; PSYCHOLOGIC TEST;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CAFFEINE; CALIFORNIA; COFFEE; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0036840451     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf119     Document Type: Article

References (49)

1. James JE. Caffeine & Health. London, England: Academic Press, 1991.
2. Barrone JJ, Roberts H. Human consumption of caffeine. In: Dews PB, ed. Caffeine. Berlin, Germany: Springer-Verlag, 1984:59-73.
3. Lienert GA, Huber H. Differential effects of coffee on speed and power tests. J Psychol 1966;63:269-74.
4. Bättig K, Buzzi R, Martin JR, et al. The effects of caffeine on physiological functions and mental performance. Experientia 1984;40:1218-23.
5. Bättig K, Buzzi R. Effect of coffee on the speed of subject-paced rapid information processing. Neuropsychobiology 1986;16:126-30.
6. Lieberman HR, Wurtman RJ, Emde GG, et al. The effects of low doses of caffeine on human performance and mood. Psychopharmacology (Berl) 1987;92:308-12.
7. Loke WH. Effects of caffeine on mood and memory. Physiol Behav 1988;44:367-72.
8. Smith AP, Rusted JM, Eaton-Williams P, et al. Effects of caffeine given before or after lunch on sustained attention. Neuropsychobiology 1990;23:160-3.
9. Frewer LJ, Lader MH. The effects of caffeine on two computerised tests of attention and vigilance. Hum Psychopharmacol 1991;6:119-28.
10. Smith AP, Brockman P, Flynn R, et al. Investigation of the effects of coffee on alertness and performance during the day and night. Neuropsychobiology 1993;27:217-23.
11. Smith AP, Maben A, Brockman P. Effects of caffeine and evening meals on sleep and performance, mood and cardiovascular functioning the following day. J Psychopharmacol 1993;27:203-6.
12. Lorist MM, Snel J, Kok A. Influence of caffeine on information processing stages in well rested and fatigued subjects. Psychopharmacology (Berl) 1994;113:411-21.
13. Reidel W, Hogervorst R, Leboux F, et al. Caffeine attenuates scopolamine-induced memory impairments in humans. Psychopharmacology (Berl) 1995;122:158-68.
14. Durlach PJ. The effects of a low dose of caffeine on cognitive performance. Psychopharmacology (Berl) 1998;140:116-19.
15. Hindmarch I, Quinlan PT, Moore KL, et al. The effects of black tea and other beverages on aspects of cognition and psychomotor performance. Psychopharmacology (Berl) 1998;139:230-8.
16. Jung RE, Yeo RA, Gangestad SW. Developmental instability predicts individual variation in verbal memory skill after caffeine ingestion. Neuropsychiatry Neuropsychol Behav Neurol 2000;13:195-8.
17. Jarvis MJ. Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology (Berl) 1993;110:45-52.
18. Reidel WJ, Jolles J. Cognition enhancers in age-related cognitive decline. Drugs Aging 1996;8:245-74.
19. Powell DH, Whitla DK. Normal cognitive aging: Toward empirical perspectives. Curr Dir Psychol Sci 1994;3:27-31.
20. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
21. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
22. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 2nd Ed. New York, NY: Oxford University Press, 1998.
23. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-25.
24. Russell EW. A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol 1975;43:800-9.
25. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
27. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 1992;40:922-35.
28. Reitan R. Validity of the Trail-Making Test as an indicator of organic brain disease. Percept Mot Skills 1958;8:271-6.
29. Borkowski JB, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5:135-40.
30. Dodrill CB. Myths of neuropsychology: Further considerations. Clin Neuropsychol 1999;13:562-72.
31. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
32. Swift CG, Tiplady B. The effects of age on the response to caffeine. Psychopharmacology (Berl) 1988;94:29-31.
33. Rees K, Allen D, Lader M. The influences of age and caffeine on psychomotor and cognitive function. Psychopharmacology (Berl) 1999;145:181-8.
34. Shadlen MF, Larson EB. What's new in Alzheimer's disease treatment: Reasons for optimism about future pharmacologic options. Postgrad Med 1999;105:109-18.
35. Molchan SE, Martinez RA, Hill JL, et al. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res Brain Res Rev 1992;17:215-26.
36. Fredholm BB. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995;76:93-101.
37. 2 receptor antagonists. Psychopharmacology (Berl) 1999;146:214-19.
38. 1) receptors by caffeine treatment. Neurosci Lett 1989;103:275-80.
39. 1-antagonists for treatment of cognitive deficits. Nucleosides Nucleotides 1991;5:1067.
40. 1 receptor agonist and antagonist on spatial learning and memory. Eur J Pharmacol 1993;249:271-80.
41. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000;283:2674-9.
42. Rinne JO, Portin R, Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 2000;57:470-5.
43. Carrillo JA, Benitez J. CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. Br J Clin Pharmacol 1996;41:605-8.
44. Relling MV, Lin JS, Ayers GD, et al. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activities. Clin Pharmacol Ther 1992;52:643-58.
45. Gao S, Hendrie HC, Hall KS, et al. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis. Arch Gen Psychiatry 1998;55:809-15.
46. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA 1997;278:1349-56.
47. James JE, Bruce MS, Lader MH, et al. Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol 1989;27:507-14.
48. Sobell J, Block G, Koslowe P, et al. Validation of a retrospective questionnaire assessing diet 10-15 years ago. Am J Epidemiol 1989;130:173-87.
49. Stavric B. An update on research with coffee/caffeine (1989-1990). Food Chem Toxicol 1992;30:533-55.